FPFS-1169

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameFPFS-1169

Drug Alias NameBenzofuranylpropylaminopentane1-(benzofuran-2-yl)-2-propylaminopentaneR-(-)-1-(benzofuran-2-yl)-2-propylaminopentane-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochlorideBPAP-cpd +[8]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionApoptosis regulator Bcl-2 stimulantsCatecholamine receptors agonistsApoptosis inhibitors

TargetsApoptosis regulator Bcl-2Catecholamine receptors

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesFujimoto Pharmaceutical

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFujimoto Pharmaceutical

Active IndicationsN/A

Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A